Jun 11,2019

Molecular Diagnostics for Oncology - Global Market Size, Strategy and Forecasts 2019-2023

A market that just keeps on growing. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge. Learn all about it in this new report from the author. A range of dynamic trends are pushing market growth and company valuations.

View Analyst & Ambassador Comments
Go to original news
Jun 01,2019

West Cancer Center Implements Flatiron Revenue Cycle Management

Flatiron Health announced today that West Cancer Center and Research Institute fully implemented their Flatiron Revenue Cycle Management service to optimize their financial performance. Flatiron’s Revenue Cycle Management Services offering combines technology and services that deliver long-term financial value to practices through a combination of oncology billing and workflow expertise, financial performance analytics and strategic advisory services.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jul 18,2019

The Moovcare app, against lung cancer, soon to be reimbursed

Remote monitoring software in lung cancer, Moovcare, received a favorable opinion from the Haute Autorité de Santé for its reimbursement, which should be granted before the end of the year. HAS issued an advisory on April 9, favorable for support by the health insurance of Moovcare, developed by the Sivan company, with a service improvement note expected level III (moderate). At stretching the planned national launch at the end of 2019, the application has already been in disposal of about fifty patients in a dozen centers French, including the Institut Curie.

PRODUCT

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 18,2019

Hillel’s Tech Corner: Making cancer patients belong

BELONG USERS can post anonymously, giving them the freedom to ask questions they might feel uncomfortable asking their doctor. Discussions on Belong’s forums range from sexuality to cannabis, alternative medicine and more.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 07,2019

Big Questions Around Diagnostics and Technology to be Discussed at UK Imaging & Oncology Congress

Delegates at the UK Imaging & Oncology Congress (UKIO) will be able to engage with global healthcare technology specialist Change Healthcare in June, around some of the biggest challenges facing diagnostic imaging and radiology in the NHS. Senior members of the Change Healthcare team will be available throughout the UKIO congress, being held in Liverpool from 10-12 June 2019, to discuss real challenges and developments facing the NHS, ranging from advances in artificial intelligence through to navigating region wide approaches to diagnostics. UKIO is the new permanent amalgamation of two well-known conferences - the UK Radiological Congress (UKRC) and the UK Radiation Oncology Conference (UKRO).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jul 31,2019

Voluntis announces market authorization for Oleena™, first digital therapeutic in oncology

Voluntis (Euronext Paris, Ticker: VTX – ISIN: FR0004183960), a leader in digital therapeutics, today announced it has successfully completed a U.S. Food and Drug Administration (FDA) regulatory review of its Oleena™ software for oncology-related symptoms management and remote patient monitoring. Oleena™ is determined as Class II medical device falling under enforcement discretion per FDA Guidance.

REGULATORY FDA

#dtx

#rpm

#coaching

View Analyst & Ambassador Comments
Go to original news
Aug 22,2019

White Paper | DermEngine’s AI Algorithms For The Future of Dermatology

Skin cancer is something that affects us all. Accounting for one third of all cancer cases, the number of new diagnoses is rising at an alarming rate, increasing by 7.7% in 2019 alone. In addition to being the most common form of cancer, it is also one of the most treatable.

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 30,2019

Supporting DermDetect To Provide Accessible Skin Imaging Services

MetaOptima is pleased to announce a partnership with DermDetect to support the mission of providing accessible skin imaging services. Based in the US, DermDetect provides mobile and affordable skin cancer screening services, and offers 1056 office locations in over 900 cities to ensure that. Through this partnership, once a patient arrives and checks in, they will have their total body photography images captured and uploaded to DermEngine.

COLLABORATION PARTNERSHIP

#product & service

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 01,2019

Flatiron Health Announces Three Publications Studying a Feasible, Reliable, Scalable and Meaningful Real-World Progression Endpoint for Oncology Research

Today, Flatiron Health announced a series of three research publications that developed and evaluated a new approach to capture when a patient’s cancer has worsened based on information contained in the electronic health record (EHR). These manuscripts illustrate the potential impact for research conducted from data collected as part of routine clinical care (real-world data).

CLINICAL STUDY

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Aug 26,2019

Blood Cancer Awareness Month - Cutting Edge Innovation in Hematology & Going Big on Data for Blood Cancers

Novartis is focused on reimagining cancer care through four distinct therapeutic platforms – targeted therapies, cell and gene therapy, immunotherapy and radioligand therapy. These platforms place Novartis at the cutting edge of blood cancer treatment. The Company proud to have revolutionized oncology research, particularly within CML. Its targeted therapies have helped transform CML from a life-limiting disease to a chronic one for many patients – with the opportunity to attempt treatment-free remission. Looking ahead, early studies combining an investigational treatment with current standards of care have shown the potential to advance CML patient care further.

PRODUCT

#platform

#big data

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY